Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip ; day:17 ; month:05 ; year:2023 ; extent:12
Advanced healthcare materials ; (17.05.2023) (gesamt 12)

Creator: Cui, Haijun
Sun, Xueyuan
Schilling, Marcel
Herold‐Mende, Christel
Reischl, Markus
Levkin, Pavel A.
Popova, Anna A.
Turcan, S̨evin

DOI: 10.1002/adhm.202300591

URN: urn:nbn:de:101:1-2023051815054088419607

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:51 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Cui, Haijun
Sun, Xueyuan
Schilling, Marcel
Herold‐Mende, Christel
Reischl, Markus
Levkin, Pavel A.
Popova, Anna A.
Turcan, S̨evin

Other Objects (12)

Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Graffiti | Streetart

FDA

Graffiti | Streetart

FDA

Graffiti | Streetart

FDA

Graffiti | Streetart

FDA

Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Graffiti | Streetart

FDA

Graffiti | Streetart

FDA

Graffiti | Streetart

FDA

Graffiti | Streetart

FDA

Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma

Repurposing FDA-approved drugs for anti-aging therapies

Hochschulschrift

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

Graffiti | Streetart

FDA

Graffiti | Streetart

FDA

Graffiti | Streetart

FDA

Graffiti | Streetart

FDA

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma

Repurposing FDA-approved drugs for anti-aging therapies

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

FDA

FDA

FDA

FDA

Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma

Repurposing FDA-approved drugs for anti-aging therapies

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

FDA

FDA

FDA

FDA

Investigating New Drug Options for Temozolomide Resistant IDH1 Mutant Glioma

Repurposing FDA-approved drugs for anti-aging therapies

Repurposing von FDA-approved drugs zur Therapie des humanen Cytomegalievirus

Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans

Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics

Repurposing of FDA approved ring systems through bi-directional target-ring system dual screening

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells

FDA

FDA

FDA

FDA

Related objects

Reset password